# 2026-08415: SHINE Nuke Tech Shifts License to New Entity—Isotopes on the Move

2026-08415, In the Matter of SHINE Technologies, LLC; SHINE Medical Isotope Production Facility; Direct and Indirect Transfers of License, is a Federal Register notice from Nuclear Regulatory Commission published 2026-04-30, effective 2026-04-22 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-08415
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-08415
- Title: In the Matter of SHINE Technologies, LLC; SHINE Medical Isotope Production Facility; Direct and Indirect Transfers of License
- Type: Notice
- Agencies: Nuclear Regulatory Commission
- Citation: 91 FR 23314
- Published: 2026-04-30
- Effective: 2026-04-22
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

SHINE Nuke Tech Shifts License to New Entity—Isotopes on the Move

## Summary

The Nuclear Regulatory Commission just gave the green light for SHINE Technologies to transfer its construction permit for the SHINE Medical Isotope Production Facility to a new company called SHINE Chrysalis, LLC. This change also involves a new parent company, SHINE Chrysalis Holdings, LLC, and is effective for one year starting April 22, 2026. This move keeps the project on track without any extra costs or delays for now.

## Abstract

The U.S. Nuclear Regulatory Commission (NRC) is issuing an order approving the license transfer application filed by SHINE Technologies, LLC, dated February 4, 2026, as supplemented on April 13, 2026. Specifically, the order approves the direct transfer of Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility from SHINE Technologies, LLC to SHINE Chrysalis, LLC and a conforming license amendment. The order also approves the indirect transfer of control of the construction permit as a result of the establishment of SHINE Chrysalis Holdings, LLC as the direct parent company of SHINE Chrysalis, LLC. SHINE Chrysalis Holdings, LLC is a wholly owned subsidiary of Illuminated Holdings, Inc., the current parent company of SHINE Technologies, LLC.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-19568](https://policyrisk.com/federal-register/2026-19568): Regulatory Enhancements for Reactor Licensing, Decommissioning, and Operational Oversight, 2026-09-24
- [2026-14341](https://policyrisk.com/federal-register/2026-14341): Modernizing Reactor Licensing, Safety Oversight, and Siting Practices, 2026-07-16
- [2026-13687](https://policyrisk.com/federal-register/2026-13687): Implementation of the National Environmental Policy Act, 2026-07-07
- [2026-12067](https://policyrisk.com/federal-register/2026-12067): Fee Schedules; Fee Recovery for Fiscal Year 2026, 2026-06-16
- [2026-08550](https://policyrisk.com/federal-register/2026-08550): Licensing Requirements for Microreactors and Other Reactors With Comparable Risk Profiles, 2026-05-01
- [2026-08015](https://policyrisk.com/federal-register/2026-08015): Generic Environmental Impact Statement for Licensing of New Nuclear Reactors, 2026-04-24

## Sources
- [2026-08415 on federalregister.gov](https://www.federalregister.gov/documents/2026/04/30/2026-08415/in-the-matter-of-shine-technologies-llc-shine-medical-isotope-production-facility-direct-and)
- [2026-08415 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-04-30/pdf/2026-08415.pdf)

## Related
- [Previous: 2026-08414, Notice of Public Meeting of the Rhode Island Advisory Committee to the U.S. Com…](https://policyrisk.com/federal-register/2026-08414)
- [Next: 2026-08417, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2026-08417)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-08415 (as of 2026-06-08).
